fda approvals in myeloma and itp, applications accepted in myeloma and more
Published 5 years ago • 139 plays • Length 10:47
Download video MP4
Download video MP3
Similar videos
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
8:29
fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
0:45
fda approval of teclistamab for r/r multiple myeloma and the value of immunotherapies
-
3:26
what does the fda approval of mrd testing for myeloma mean for patients and drug development?
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
7:49
fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
-
1:07
fda approval of frontline daratumumab plus vmp in multiple myeloma
-
9:53
recent fda approvals for multiple myeloma and what to expect from treatments in development
-
1:12
the recent fda approval of cilta-cel and its impact on myeloma patients in the uk
-
3:55
the association between itp and multiple myeloma
-
6:17
ash impact series: paul richardson, md - examining the new fda approved myeloma drug products
-
4:16
what is the monoclonal antibody talvey™ (talquetamab)?
Clip.africa.com - Privacy-policy